WO1999043786A3 - Submucosa gel compositions - Google Patents

Submucosa gel compositions Download PDF

Info

Publication number
WO1999043786A3
WO1999043786A3 PCT/US1999/004352 US9904352W WO9943786A3 WO 1999043786 A3 WO1999043786 A3 WO 1999043786A3 US 9904352 W US9904352 W US 9904352W WO 9943786 A3 WO9943786 A3 WO 9943786A3
Authority
WO
WIPO (PCT)
Prior art keywords
submucosa
gel compositions
composition
submucosa gel
enzymatically digested
Prior art date
Application number
PCT/US1999/004352
Other languages
French (fr)
Other versions
WO1999043786A2 (en
Inventor
Sherry L Voytik-Harbin
Andrew O Brightman
Ryan M Meixner
Beverly Z Waisner
Original Assignee
Purdue Research Foundation
Voytik Harbin Sherry L
Andrew O Brightman
Ryan M Meixner
Beverly Z Waisner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation, Voytik Harbin Sherry L, Andrew O Brightman, Ryan M Meixner, Beverly Z Waisner filed Critical Purdue Research Foundation
Priority to AU33132/99A priority Critical patent/AU743808B2/en
Priority to EP99936091A priority patent/EP1056836B1/en
Priority to CA2321117A priority patent/CA2321117C/en
Priority to US09/622,244 priority patent/US6264992B1/en
Priority to US09/911,144 priority patent/US6444229B2/en
Publication of WO1999043786A2 publication Critical patent/WO1999043786A2/en
Publication of WO1999043786A3 publication Critical patent/WO1999043786A3/en
Priority to GBGB0020704.3A priority patent/GB0020704D0/en
Priority to US10/233,888 priority patent/US7147871B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C12N2533/92—Amnion; Decellularised dermis or mucosa

Abstract

A composition comprising enzymatically digested submucosa of a warm-blooded vertebrate and a method of making that composition is described. More particularly the submucosa is enzymatically digested and gelled to form a shape retaining gel matrix suitable for inducing cell proliferation and growth both in vivo and in vitro.
PCT/US1999/004352 1998-02-27 1999-02-26 Submucosa gel compositions WO1999043786A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU33132/99A AU743808B2 (en) 1998-02-27 1999-02-26 Submucosa gel compositions
EP99936091A EP1056836B1 (en) 1998-02-27 1999-02-26 Submucosa gel compositions
CA2321117A CA2321117C (en) 1998-02-27 1999-02-26 Submucosa gel compositions
US09/622,244 US6264992B1 (en) 1998-02-27 1999-02-26 Submucosa as a growth substrate for cells
US09/911,144 US6444229B2 (en) 1998-02-27 1999-02-26 Submucosa gel compositions
GBGB0020704.3A GB0020704D0 (en) 1998-02-27 2000-08-22 Submucosa gel compositions
US10/233,888 US7147871B2 (en) 1998-02-27 2002-09-03 Submucosa gel compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7669098P 1998-02-27 1998-02-27
US60/076,690 1998-02-27

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US09/911,144 Continuation US6444229B2 (en) 1998-02-27 1999-02-26 Submucosa gel compositions
US09/622,244 A-371-Of-International US6264992B1 (en) 1998-02-27 1999-02-26 Submucosa as a growth substrate for cells
US09622244 A-371-Of-International 1999-02-26
US10/233,888 Continuation US7147871B2 (en) 1998-02-27 2002-09-03 Submucosa gel compositions

Publications (2)

Publication Number Publication Date
WO1999043786A2 WO1999043786A2 (en) 1999-09-02
WO1999043786A3 true WO1999043786A3 (en) 1999-11-11

Family

ID=22133633

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/004352 WO1999043786A2 (en) 1998-02-27 1999-02-26 Submucosa gel compositions

Country Status (6)

Country Link
US (4) US6264992B1 (en)
EP (1) EP1056836B1 (en)
AU (1) AU743808B2 (en)
CA (1) CA2321117C (en)
GB (1) GB0020704D0 (en)
WO (1) WO1999043786A2 (en)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485723B1 (en) * 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US7351421B2 (en) * 1996-11-05 2008-04-01 Hsing-Wen Sung Drug-eluting stent having collagen drug carrier chemically treated with genipin
US6998418B1 (en) 1996-11-05 2006-02-14 Gp Medical, Inc. Acellular biological material chemically treated with genipin
US7101857B2 (en) * 1996-11-05 2006-09-05 Gp Medical, Inc. Crosslinkable biological material and medical uses
US7282220B1 (en) 1996-11-05 2007-10-16 Hsing-Wen Sung Genipin-crosslinked gelatin microspheres as drug carrier
US6545042B2 (en) 1996-11-05 2003-04-08 Gp Medical Acellular biological material chemically treated with genipin
US6624138B1 (en) 2001-09-27 2003-09-23 Gp Medical Drug-loaded biological material chemically treated with genipin
JP2002531181A (en) * 1998-12-01 2002-09-24 クック・バイオテック・インコーポレーテッド Polymorphic collagen biomaterial medical device
JP2005524426A (en) * 2002-05-02 2005-08-18 パーデュー・リサーチ・ファウンデーション Graft composition with enhanced angiogenesis
JP2005524699A (en) * 2002-05-02 2005-08-18 パーデュー・リサーチ・ファウンデーション Graft composition with enhanced angiogenesis
JP2005533535A (en) * 2002-05-02 2005-11-10 パーデュー・リサーチ・ファウンデーション Graft composition with enhanced angiogenesis
US7550004B2 (en) * 2002-08-20 2009-06-23 Cook Biotech Incorporated Endoluminal device with extracellular matrix material and methods
GB2443335B (en) * 2003-08-25 2008-06-18 Cook Biotech Inc Graft materials
US8741352B2 (en) * 2003-08-25 2014-06-03 Cook Biotech Incorporated Graft materials containing ECM components, and methods for their manufacture
GB2424586B (en) * 2003-08-25 2008-05-28 Cook Biotech Inc Graft materials containing bioactive substances, and methods for their manufacture
US20050054099A1 (en) * 2003-09-04 2005-03-10 Cedars Sinai Medical Center Matrix derived from whole organ
NZ547140A (en) * 2003-10-22 2009-09-25 Encelle Inc Bioactive hydrogel compositions in dehydrated form for regenerating connective tissue
US8916184B2 (en) * 2003-11-07 2014-12-23 University Of Connecticut Artificial tissue systems and uses thereof
CA2544734A1 (en) * 2003-11-07 2005-06-02 Hill's Pet Nutrition, Inc. Fluid composition for increased total water intake
WO2005077433A1 (en) * 2004-02-09 2005-08-25 Cook Biotech Incorporated Stent graft devices having collagen coating
US8337545B2 (en) 2004-02-09 2012-12-25 Cook Medical Technologies Llc Woven implantable device
US7449027B2 (en) * 2004-03-29 2008-11-11 Cook Incorporated Modifying fluid flow in a body vessel lumen to promote intraluminal flow-sensitive processes
DE602005020754D1 (en) * 2004-03-31 2010-06-02 Cook Inc TRANSPLANT MATERIAL AND VASCOPY THERAPY WITH EXTRACELLULAR COLLAGEN MATRIX AND ITS MANUFACTURING PROCESS
CA2565203A1 (en) * 2004-03-31 2005-10-20 Cook Incorporated Ecm-based graft material
US8216299B2 (en) 2004-04-01 2012-07-10 Cook Medical Technologies Llc Method to retract a body vessel wall with remodelable material
US20060009835A1 (en) * 2004-07-07 2006-01-12 Osborne Thomas A Graft, stent graft and method
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US7442206B2 (en) * 2004-10-28 2008-10-28 Cook Incorporated Methods and systems for modifying vascular valves
US7387604B2 (en) * 2004-11-03 2008-06-17 Cook Incorporated Methods for treating valve-associated regions of vascular vessels
US7905826B2 (en) * 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
WO2006062976A2 (en) * 2004-12-07 2006-06-15 Cook Incorporated Methods for modifying vascular vessel walls
US8066732B2 (en) * 2004-12-30 2011-11-29 Cook Incorporated Inverting occlusion devices, methods, and systems
US20060246033A1 (en) * 2005-03-02 2006-11-02 Cook Biotech Incorporated Injectable bulking agent compositions
US8197534B2 (en) * 2005-03-31 2012-06-12 Cook Medical Technologies Llc Valve device with inflatable chamber
GB2463811B (en) * 2005-05-16 2010-05-05 Purdue Research Foundation Engineered extracellular matrices
US8518436B2 (en) * 2005-05-16 2013-08-27 Purdue Research Foundation Engineered extracellular matrices
US20070061002A1 (en) * 2005-09-01 2007-03-15 Cook Incorporated Attachment of material to an implantable frame by cross-linking
US9308252B2 (en) * 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US8802113B2 (en) * 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
WO2007081530A2 (en) * 2006-01-03 2007-07-19 Med Institute, Inc. Endoluminal medical device for local delivery of cathepsin inhibitors
WO2007098234A2 (en) * 2006-02-21 2007-08-30 Med Institute, Inc. Graft material for prostheses
US7648527B2 (en) * 2006-03-01 2010-01-19 Cook Incorporated Methods of reducing retrograde flow
DE112007001197T5 (en) * 2006-05-16 2009-04-16 Purdue Research Foundation, West Lafayette Three-dimensional purified collagen matrices
US20070269476A1 (en) 2006-05-16 2007-11-22 Voytik-Harbin Sherry L Engineered extracellular matrices control stem cell behavior
US8084055B2 (en) * 2006-09-21 2011-12-27 Purdue Research Foundation Collagen preparation and method of isolation
US8343536B2 (en) * 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
US9056151B2 (en) 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
WO2008109407A2 (en) 2007-03-02 2008-09-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Extracellular matrix-derived gels and related methods
US20080279833A1 (en) * 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
WO2009036250A1 (en) 2007-09-12 2009-03-19 Cook Incorporated Enhanced remodelable materials for occluding bodily vessels and related methods and systems
US7846199B2 (en) 2007-11-19 2010-12-07 Cook Incorporated Remodelable prosthetic valve
EP2222159B1 (en) 2007-11-20 2018-02-21 Pioneer Surgical Orthobiologics, Inc. Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles
WO2009076441A1 (en) * 2007-12-10 2009-06-18 Purdue Research Foundation Collagen-based matrices with stem cells
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US9817822B2 (en) * 2008-02-07 2017-11-14 International Business Machines Corporation Managing white space in a portal web page
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
US8858698B2 (en) * 2008-09-05 2014-10-14 Mentor Worldwide Llc Acellular matrix glue
US7927414B2 (en) * 2008-09-05 2011-04-19 Ethicon, Inc. Method of manufacturing acellular matrix glue
WO2010088678A2 (en) 2009-02-02 2010-08-05 Cook Biotech Incorporated Medical bead products
PL3000472T3 (en) * 2009-02-18 2017-09-29 Cormatrix Cardiovascular, Inc. Compositions for preventing atrial and ventricular fibrillation
JP5693475B2 (en) * 2009-03-04 2015-04-01 ペイタント・ソリューションズ・インコーポレイテッドＰｅｙｔａｎｔ Ｓｏｌｕｔｉｏｎｓ， Ｉｎｃ． Stent modified with a material comprising amnion tissue and corresponding method
CA2760889C (en) 2009-05-06 2017-09-19 Hansa Medical Products, Inc. Self-adjusting medical device
WO2011022045A2 (en) * 2009-08-17 2011-02-24 Singh Ashok K Apparatus and process for generating and harvesting adult stem cells and fluid associated with it from skin and omentum for medical, cosmetic, and veterinary use
US8846059B2 (en) 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
US20110150934A1 (en) * 2009-12-18 2011-06-23 University Of Notre Dame Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
WO2012024390A2 (en) 2010-08-17 2012-02-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biohybrid composite scaffold
DK2608777T3 (en) 2010-08-24 2019-10-28 Univ California Compositions and Methods for Cardiac Therapy
JP2014533119A (en) 2011-05-27 2014-12-11 コーマトリックス カーディオバスキュラー， インコーポレイテッドＣｏｒＭａｔｒｉｘ Ｃａｒｄｉｏｖａｓｃｕｌａｒ， Ｉｎｃ． Valve conduit for extracellular matrix material and method for making the same
JP2014532713A (en) 2011-11-02 2014-12-08 ハルシオン，インコーポレイテッド Wound treatment methods and compositions
EP2793963B1 (en) 2011-12-23 2015-11-18 Pioneer Surgical Technology, Inc. Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith
EP2811939B8 (en) 2012-02-10 2017-11-15 CVDevices, LLC Products made of biological tissues for stents and methods of manufacturing
JP6466323B2 (en) * 2012-06-14 2019-02-06 グライナー バイオ‐ワン ノース アメリカ，インコーポレイテッド Magnetic extracellular matrix
US20140228937A1 (en) 2013-02-11 2014-08-14 Joshua Krieger Expandable Support Frame and Medical Device
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
WO2015066377A1 (en) 2013-10-30 2015-05-07 The Curators Of The University Of Missouri Method for scalable skeletal muscle lineage specification and cultivation
JP6681872B2 (en) 2014-03-21 2020-04-15 ユニバーシティ オブ ピッツバーグ −オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション Method for preparing final sterile hydrogel derived from extracellular matrix
WO2016172365A1 (en) 2015-04-21 2016-10-27 Purdue Research Foundation Office Of Technology Commercialization Cell-collagen-silica composites and methods of making and using the same
WO2017062762A2 (en) 2015-10-07 2017-04-13 Sigmon John C Methods, medical devices and kits for modifying the luminal profile of a body vessel
AU2018226871B2 (en) 2017-03-02 2023-08-10 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Extracellular matrix (ECM) hydrogel and soluble fraction thereof for the treatment of cancer
KR20190120258A (en) 2017-03-02 2019-10-23 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 ECM hydrogel for the treatment of esophageal inflammation
WO2018200750A1 (en) 2017-04-25 2018-11-01 Purdue Research Foundation 3-dimensional (3d) tissue-engineered muscle for tissue restoration
WO2019014652A1 (en) 2017-07-13 2019-01-17 Memphis Meats, Inc. Compositions and methods for increasing the efficiency of cell cultures used for food production

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
WO1996024661A1 (en) * 1995-02-10 1996-08-15 Purdue Research Foundation Submucosa as a growth substrate for cells
WO1998025964A1 (en) * 1996-12-10 1998-06-18 Purdue Research Foundation Submucosa extracts

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4956178A (en) * 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US5281422A (en) * 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5641518A (en) * 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
EP0946186B1 (en) * 1996-12-10 2003-03-26 Purdue Research Foundation Stomach submucosa derived tissue graft

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
WO1996024661A1 (en) * 1995-02-10 1996-08-15 Purdue Research Foundation Submucosa as a growth substrate for cells
WO1998025964A1 (en) * 1996-12-10 1998-06-18 Purdue Research Foundation Submucosa extracts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VOYTIK-HARBIN, SHERRY L. (1) ET AL: "Small intestinal submucosa: A tissue-derived extracellular matrix that promotes tissue-specific growth and differentiation of cells in vitro.", TISSUE ENGINEERING, (SUMMER, 1998) VOL. 4, NO. 2, PP. 157-174., XP002114302 *

Also Published As

Publication number Publication date
EP1056836A2 (en) 2000-12-06
WO1999043786A2 (en) 1999-09-02
AU743808B2 (en) 2002-02-07
EP1056836B1 (en) 2009-02-18
US20030012822A1 (en) 2003-01-16
CA2321117A1 (en) 1999-09-02
US20020001626A1 (en) 2002-01-03
CA2321117C (en) 2014-07-15
GB0020704D0 (en) 2000-10-11
US6264992B1 (en) 2001-07-24
US7147871B2 (en) 2006-12-12
AU3313299A (en) 1999-09-15
US6444229B2 (en) 2002-09-03
US20030012823A1 (en) 2003-01-16

Similar Documents

Publication Publication Date Title
WO1999043786A3 (en) Submucosa gel compositions
EP1449916A3 (en) Submucosa as a growth substrate for cells
EP1650307A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
AU2193500A (en) Methods of preparing prismatic cells and prismatic cells prepared by such methods
AU1287895A (en) Differentially biodegradable biomedical implants
PL332031A1 (en) Method of and composition fo rtreating substrates in order to make them vettable
AU3171399A (en) Solid electrolyte fuel cell and method of producing the same
AU5202499A (en) Fuel cell tubes and method of making same
AU2260097A (en) Hematopoietic cell culture nutrient supplement
NL300754I2 (en)
WO2000005381A3 (en) Expression of enzymes involved in cellulose modification
AU4323599A (en) Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
AU4094099A (en) Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
AU4926897A (en) Method of producing semiconductor member and method of producing solar cell
EP0796914A3 (en) Alcohol dehydrogenase and its use in the enzymatic production of chiral hydroxy-compounds
AU4900585A (en) Inductive collagen based bone repair preparations
EP0743981A4 (en) High performance cell culture bioreactor and method
AU6266398A (en) Method of preparing electrochemical cells
AU2051600A (en) Compositions and methods of modulating cholesterol metabolism
PL336983A1 (en) Compounds, their production and application as carriers of nucleic acids in cells
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
AU7576100A (en) Methods of making mesoporous metal oxide compositions and solid oxide fuel cells
AU3392697A (en) (in vitro) derivation and culture of primate pluripotent stem cells and therapeutic uses thereof
IL146397A0 (en) Ex vivo expansion of mammalian hematopoietic stem cells
AU1674597A (en) Modification of polysaccharides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 09622244

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2321117

Country of ref document: CA

Ref document number: 2321117

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: GB0020704.3

Country of ref document: GB

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 33132/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999936091

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999936091

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 33132/99

Country of ref document: AU